Home Cart Sign in  
Chemical Structure| 152121-30-7 Chemical Structure| 152121-30-7

Structure of SB 202190
CAS No.: 152121-30-7

Chemical Structure| 152121-30-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SB-202190 is a highly selective, potent and cell-permeable inhibitor of p38 MAP kinase with IC50 values of 50 nM and 100 nM for p38α and p38β respectively; also shows slightly weaker activity for BRD4 (Kd=3.4 μM).

Synonyms: FHPI

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SB 202190

CAS No. :152121-30-7
Formula : C20H14FN3O
M.W : 331.34
SMILES Code : OC1=CC=C(C2=NC(C3=CC=C(F)C=C3)=C(C4=CC=NC=C4)N2)C=C1
Synonyms :
FHPI
MDL No. :MFCD00941964
InChI Key :QHKYPYXTTXKZST-UHFFFAOYSA-N
Pubchem ID :5169

Safety of SB 202190

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of SB 202190

GPCR
MAPK
TLR

Isoform Comparison

Biological Activity

Target
  • p38β

    p38β, IC50:100 nM

  • p38α

    p38α, IC50:50 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
A6 cells 10 µM 30 min To inhibit p38 MAPK activity and study its role under oxidative stress. PMC5849040
HaCaT cells 10 μM Inhibition of p38 MAPK prevented pemphigus IgG-triggered keratinocyte dissociation PMC2064672
ts20 cells 30 µM 20 h SB 202190 inhibits p38 MAPK signaling, reducing the steady-state levels of p73 and dramatically attenuating the ability of PML to prevent its degradation. PMC2211783
NMuMG cells 20 μM 24 h Inhibition of p38 prevents the increase in truncated Gja1 5′ UTRs M and S following TGF- β treatment PMC6857847
astrocytes 7 µg/mL 30 min Inhibit the P38 pathway, reduce the expression of versican in inflammation-induced astrocytes PMC10479858

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
mice spinal cord injury model intraperitoneal injection 5 mg/kg once a day for 7 days Inhibit the P38 pathway, reduce the expression of versican after spinal cord injury, promote axonal regeneration and neuronal survival PMC10479858

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.02mL

0.60mL

0.30mL

15.09mL

3.02mL

1.51mL

30.18mL

6.04mL

3.02mL

References

 

Historical Records

Categories